378 related articles for article (PubMed ID: 23374900)
1. A novel mutation in the DNM2 gene impairs dynamin 2 localization in skeletal muscle of a patient with late onset centronuclear myopathy.
Kierdaszuk B; Berdynski M; Karolczak J; Redowicz MJ; Zekanowski C; Kaminska AM
Neuromuscul Disord; 2013 Mar; 23(3):219-28. PubMed ID: 23374900
[TBL] [Abstract][Full Text] [Related]
2. A centronuclear myopathy-dynamin 2 mutation impairs skeletal muscle structure and function in mice.
Durieux AC; Vignaud A; Prudhon B; Viou MT; Beuvin M; Vassilopoulos S; Fraysse B; Ferry A; Lainé J; Romero NB; Guicheney P; Bitoun M
Hum Mol Genet; 2010 Dec; 19(24):4820-36. PubMed ID: 20858595
[TBL] [Abstract][Full Text] [Related]
3. Adult course in dynamin 2 dominant centronuclear myopathy with neonatal onset.
Melberg A; Kretz C; Kalimo H; Wallgren-Pettersson C; Toussaint A; Böhm J; Stålberg E; Laporte J
Neuromuscul Disord; 2010 Jan; 20(1):53-6. PubMed ID: 19932619
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of wild-type or a centronuclear myopathy mutant of dynamin 2 in skeletal muscle of adult mice leads to structural defects and muscle weakness.
Cowling BS; Toussaint A; Amoasii L; Koebel P; Ferry A; Davignon L; Nishino I; Mandel JL; Laporte J
Am J Pathol; 2011 May; 178(5):2224-35. PubMed ID: 21514436
[TBL] [Abstract][Full Text] [Related]
5. Histopathologic changes in the extraocular muscle in centronuclear myopathy with a Dynamin 2 mutation.
Hanna N; Bouhenni R; Gupta B; Abu-Amero KK; Wollmann R; Edward DP
Ophthalmic Genet; 2013; 34(1-2):83-6. PubMed ID: 22924779
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological features of centronuclear myopathy in Japanese populations harboring mutations in dynamin 2.
Mori-Yoshimura M; Okuma A; Oya Y; Fujimura-Kiyono C; Nakajima H; Matsuura K; Takemura A; Malicdan MC; Hayashi YK; Nonaka I; Murata M; Nishino I
Clin Neurol Neurosurg; 2012 Jul; 114(6):678-83. PubMed ID: 22613877
[TBL] [Abstract][Full Text] [Related]
7. Subtle central and peripheral nervous system abnormalities in a family with centronuclear myopathy and a novel dynamin 2 gene mutation.
Echaniz-Laguna A; Nicot AS; Carré S; Franques J; Tranchant C; Dondaine N; Biancalana V; Mandel JL; Laporte J
Neuromuscul Disord; 2007 Dec; 17(11-12):955-9. PubMed ID: 17825552
[TBL] [Abstract][Full Text] [Related]
8. Expanding the clinical, pathological and MRI phenotype of DNM2-related centronuclear myopathy.
Susman RD; Quijano-Roy S; Yang N; Webster R; Clarke NF; Dowling J; Kennerson M; Nicholson G; Biancalana V; Ilkovski B; Flanigan KM; Arbuckle S; Malladi C; Robinson P; Vucic S; Mayer M; Romero NB; Urtizberea JA; García-Bragado F; Guicheney P; Bitoun M; Carlier RY; North KN
Neuromuscul Disord; 2010 Apr; 20(4):229-37. PubMed ID: 20227276
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the muscle involvement in dynamin 2-related centronuclear myopathy.
Fischer D; Herasse M; Bitoun M; Barragán-Campos HM; Chiras J; Laforêt P; Fardeau M; Eymard B; Guicheney P; Romero NB
Brain; 2006 Jun; 129(Pt 6):1463-9. PubMed ID: 16585051
[TBL] [Abstract][Full Text] [Related]
10. Muscle-specific function of the centronuclear myopathy and Charcot-Marie-Tooth neuropathy-associated dynamin 2 is required for proper lipid metabolism, mitochondria, muscle fibers, neuromuscular junctions and peripheral nerves.
Tinelli E; Pereira JA; Suter U
Hum Mol Genet; 2013 Nov; 22(21):4417-29. PubMed ID: 23813975
[TBL] [Abstract][Full Text] [Related]
11. MRI in DNM2-related centronuclear myopathy: evidence for highly selective muscle involvement.
Schessl J; Medne L; Hu Y; Zou Y; Brown MJ; Huse JT; Torigian DA; Jungbluth H; Goebel HH; Bönnemann CG
Neuromuscul Disord; 2007 Jan; 17(1):28-32. PubMed ID: 17134899
[TBL] [Abstract][Full Text] [Related]
12. [The dynamin-2-gene related centronuclear myopathy].
Bitoun M
Med Sci (Paris); 2023 Nov; 39 Hors série n° 1():6-10. PubMed ID: 37975763
[TBL] [Abstract][Full Text] [Related]
13. Dynamin 2 mutations cause sporadic centronuclear myopathy with neonatal onset.
Bitoun M; Bevilacqua JA; Prudhon B; Maugenre S; Taratuto AL; Monges S; Lubieniecki F; Cances C; Uro-Coste E; Mayer M; Fardeau M; Romero NB; Guicheney P
Ann Neurol; 2007 Dec; 62(6):666-70. PubMed ID: 17932957
[TBL] [Abstract][Full Text] [Related]
14. Adult-onset autosomal dominant centronuclear myopathy due to BIN1 mutations.
Böhm J; Biancalana V; Malfatti E; Dondaine N; Koch C; Vasli N; Kress W; Strittmatter M; Taratuto AL; Gonorazky H; Laforêt P; Maisonobe T; Olivé M; Gonzalez-Mera L; Fardeau M; Carrière N; Clavelou P; Eymard B; Bitoun M; Rendu J; Fauré J; Weis J; Mandel JL; Romero NB; Laporte J
Brain; 2014 Dec; 137(Pt 12):3160-70. PubMed ID: 25260562
[TBL] [Abstract][Full Text] [Related]
15. Different in vivo impacts of dynamin 2 mutations implicated in Charcot-Marie-Tooth neuropathy or centronuclear myopathy.
Massana Muñoz X; Buono S; Koebel P; Laporte J; Cowling BS
Hum Mol Genet; 2019 Dec; 28(24):4067-4077. PubMed ID: 31628461
[TBL] [Abstract][Full Text] [Related]
16. Sporadic centronuclear myopathy with muscle pseudohypertrophy, neutropenia, and necklace fibres due to a DNM2 mutation.
Romero NB; Bevilacqua JA; Oldfors A; Fardeau M
Neuromuscul Disord; 2011 Feb; 21(2):148; author reply 148-9. PubMed ID: 21247764
[No Abstract] [Full Text] [Related]
17. Adult centronuclear myopathies: A hospital-based study.
Echaniz-Laguna A; Biancalana V; Böhm J; Tranchant C; Mandel JL; Laporte J
Rev Neurol (Paris); 2013; 169(8-9):625-31. PubMed ID: 23938035
[TBL] [Abstract][Full Text] [Related]
18. Mutations in dynamin 2 cause dominant centronuclear myopathy.
Bitoun M; Maugenre S; Jeannet PY; Lacène E; Ferrer X; Laforêt P; Martin JJ; Laporte J; Lochmüller H; Beggs AH; Fardeau M; Eymard B; Romero NB; Guicheney P
Nat Genet; 2005 Nov; 37(11):1207-9. PubMed ID: 16227997
[TBL] [Abstract][Full Text] [Related]
19. Nuclear defects in skeletal muscle from a Dynamin 2-linked centronuclear myopathy mouse model.
Fongy A; Falcone S; Lainé J; Prudhon B; Martins-Bach A; Bitoun M
Sci Rep; 2019 Feb; 9(1):1580. PubMed ID: 30733559
[TBL] [Abstract][Full Text] [Related]
20. Sporadic centronuclear myopathy with muscle pseudohypertrophy, neutropenia, and necklace fibers due to a DNM2 mutation.
Liewluck T; Lovell TL; Bite AV; Engel AG
Neuromuscul Disord; 2010 Dec; 20(12):801-4. PubMed ID: 20817456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
